These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 152171)

  • 1. Hypersensitivity pneumonitis with antibodies to Cryptococcus neoformans.
    Miyagawa T; Ochi T; Takahashi H
    Clin Allergy; 1978 Sep; 8(5):501-9. PubMed ID: 152171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese summer-type hypersensitivity pneumonitis: studies using Cryptococcus antigen.
    Miyagawa T; Hamagami S; Ochi T; Osugi T; Kikui M; Takahashi H
    Clin Allergy; 1982 Jul; 12(4):343-54. PubMed ID: 6749330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of Trichosporon cutaneum and Cryptococcus neoformans antigens by crossed immunoelectrophoresis using antiserum, sera and bronchoalveolar lavage fluid obtained from patients with summer-type hypersensitivity pneumonitis].
    Miyagawa T; Hamagami S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Nov; 26(11):1142-9. PubMed ID: 3074210
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypersensitivity pneumonitis induced by Trichosporon cutaneum.
    Shimazu K; Ando M; Sakata T; Yoshida K; Araki S
    Am Rev Respir Dis; 1984 Sep; 130(3):407-11. PubMed ID: 6433758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus albidus-induced summer-type hypersensitivity pneumonitis.
    Miyagawa T; Hamagami S; Tanigawa N
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):961-6. PubMed ID: 10712349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans.
    Kozel TR; Cazin J
    Mycopathol Mycol Appl; 1974 Oct; 54(1):21-30. PubMed ID: 4139653
    [No Abstract]   [Full Text] [Related]  

  • 7. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.
    Dromer F; Salamero J; Contrepois A; Carbon C; Yeni P
    Infect Immun; 1987 Mar; 55(3):742-8. PubMed ID: 3546139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcus neoformans antibody levels in patients with AIDS.
    Dromer F; Aucouturier P; Clauvel JP; Saimot G; Yeni P
    Scand J Infect Dis; 1988; 20(3):283-5. PubMed ID: 3043650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on 42 cases of hypersensitivity pneumonitis (author's transl)].
    Ochi T; Miyagawa T; Osugi T; Fujita K; Yamamoto H; Kikui M; Takahashi H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 May; 16(5):320-8. PubMed ID: 702957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific antibody-forming cells in bronchoalveolar lavage fluid of patients with summer-type hypersensitivity pneumonitis--detection by enzyme-linked immunospot (ELISPOT)].
    Miyagawa T; Hamagami S; Ohhata I; Ochi T; Kishimoto S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):840-7. PubMed ID: 7690077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate hypersensitivity to Cryptococcus neoformans.
    Tang YJ; Morelli R
    Infect Immun; 1981 Feb; 31(2):842-4. PubMed ID: 7012025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
    Kozel TR; Follette JL
    Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic evidence for Cryptococcus neoformans infection in early childhood.
    Goldman DL; Khine H; Abadi J; Lindenberg DJ; Pirofski La ; Niang R; Casadevall A
    Pediatrics; 2001 May; 107(5):E66. PubMed ID: 11331716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of the specific type of capsular polysaccharide of Cryptococcus neoformans as an immunogen and positive-control antigen].
    Toraño Peraza GT; Rodríguez Acebo W; Martínez Machín G
    Rev Cubana Med Trop; 1998; 50(3):207-8. PubMed ID: 10349445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness.
    Kozel TR; Gulley WF; Cazin J
    Infect Immun; 1977 Dec; 18(3):701-7. PubMed ID: 338489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticryptococcal type D antibodies raised in rabbits.
    Bhattacharjee AK; Bennett JE; Bundle DR; Glaudemans CP
    Mol Immunol; 1983 Apr; 20(4):351-9. PubMed ID: 6191205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
    Martinez LR; Moussai D; Casadevall A
    Infect Immun; 2004 Jun; 72(6):3674-9. PubMed ID: 15155683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.
    Cleare W; Mukherjee S; Spitzer ED; Casadevall A
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):737-40. PubMed ID: 8556529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recognition of intact cells from Cryptococcus neoformans by the anti-glucuronoxylomannan 4B3 monoclonal antibody].
    Gato Armas R; Martínez Machín G; Rodríguez Sánchez H; Otero González A; Sarracent Pérez J; Illnait Zaragozi MT
    Rev Cubana Med Trop; 2006; 58(2):159-61. PubMed ID: 23427436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.